Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Merck & Co. Inc. (MRK)

79.25   0.01 (0.01%) 02-20 13:26
Open: 79 Pre. Close: 79.24
High: 79.445 Low: 78.81
Volume: 3,360,776 Market Cap: 206080M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 80.248 - 80.652 80.652 - 80.985
Low: 78.139 - 78.57 78.57 - 78.924
Close: 78.612 - 79.284 79.284 - 79.837

Technical analysis

as of: 2019-02-20 12:58:35 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 93.59     One year: 109.32
Support: Support1: 75.14    Support2: 72.05
Resistance: Resistance1: 80.13    Resistance2: 93.59
Pivot: 77.43
Moving Average: MA(5): 79.24     MA(20): 76.46
MA(100): 74.54     MA(250): 66.61
MACD: MACD(12,26): 1.17     Signal(9): 0.83
Stochastic oscillator: %K(14,3): 90.34     %D(3): 92.54
RSI: RSI(14): 63.34
52-week: High: 80.19  Low: 52.83  Change(%): 45.2
Average Vol(K): 3-Month: 1317037  10-Days: 934085

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
MRK has closed below upper band by 24.7%. Bollinger Bands are 34.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2019-02-20T12:15:09-05:00
Galectin Therapeutics Likely To Appreciate On Clinical Results, Further Partnerships

2019-02-20T11:33:00-05:00
Starboard Value has 1 million-share stake in Bristol-Myers Squibb, has met with management

2019-02-20T06:45:00-05:00
FDA Grants Priority Review to Merck's Supplemental Biologics License Application for KEYTRUDA® (pembrolizumab) Monotherapy for Third-Line Treatment of Patients with Advanced Small Cell Lung Cancer (SCLC)

2019-02-20T04:05:31-05:00
Why I Look For Dividend Growth, Not Just Dividend Safety

2019-02-20T00:47:18-05:00
The Best Dividend Stocks For New Money Today

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 2600.38
Shares Float (M) 2597.36
% Held by Insiders
% Held by Institutions 115.60
Shares Short (K) 34557
Shares Short P. Month (K)

Stock Financials

EPS 4.340
EPS Est. Current Year 3.870
EPS Est. Next Year 4.160
EPS Est. Next Quarter 0.960
Forward EPS 4.551
Book Value (p.s.) 6.300
PEG Ratio 1.78
Profit Margin 14.75
Operating Margin 23.51
Return on Assets (ttm) 7.4
Return on Equity (ttm) 18.9
Qtrly Rev. Growth 5.4
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E 18.25
P/E Growth Ratio
P/BV 12.57
P/S 13040457728.00
P/CF

Dividends & Splits

Dividend 2.757
Dividend Yield 0.03
Dividend Pay Date 2019-04-05
Ex-Dividend Date 2019-03-14
Forward Dividend 2.200
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.